Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling by Nikhar, S, Siokas, I, Schlicher, L, Lee, S, Gyrd-Hansen, M, Degterev, A, Cuny, GD

Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold by Suebsuwong, C, Dai, B, Pinkas, DM, Duddupudi, AL, Li, L, Bufton, JC, Schlicher, L, Gyrd-Hansen, M, Hu, M, Bullock, AN, Degterev, A, Cuny, GD

Regulation of CYLD activity and specificity by phosphorylation and ubiquitin-binding CAP-Gly domains by Elliott, PR, Leske, D, Wagstaff, J, Schlicher, L, Berridge, G, Maslen, S, Timmermann, F, Ma, B, Fischer, R, Freund, SMV, Komander, D, Gyrd-Hansen, M

Small-molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling by Gyrd-Hansen, M, Hdrinka, M, Schlicher, L, Dai, B, Pinkas, DM, Bufton, JC, Picaud, S, Ward, JA, Rogers, C, Huber, KVM, Filippakopoulos, P, Bullock, AN, Degterev, A